# The Ischemia Modified Albumin In Diagnosing Ischemic New Events

> **NCT00355992** · — · TERMINATED · sponsor: **Inverness Medical Innovations** · enrollment: 1250 (estimated)

## Conditions studied

- Heart Disease, Ischemic
- Ischemia, Myocardial
- Ischemic Heart Disease
- Unstable Angina

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00355992
- **Lead sponsor:** Inverness Medical Innovations
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-12
- **Target enrollment:** 1250 (ESTIMATED)
- **Last updated:** 2009-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00355992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00355992, "The Ischemia Modified Albumin In Diagnosing Ischemic New Events". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00355992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*